Many countries do not have the equivalent to the US’s Orange book, meaning...
- Pat-INFORMED: the solution to drug patent procurement issues?
- Will tech giants like Amazon and Google change the pharma sector forever?
- GM babies: He Jiankui and the ethics of gene editing
- ‘Nanocarrier’ brings hope for disease-modifying osteoarthritis drugs
- Brexit looms over UK’s attractiveness as a research destination
Merck partners with Cyclica for AI-based screening of drug targets
Merck has signed an agreement to licence Canada-based Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts.
Pat-INFORMED: the solution to drug patent procurement issues?
Many countries do not have the equivalent to the US’s Orange book, meaning that health officials are wasting time establishing whether patents have been taken out on medicines. Leading biopharmaceutical companies have worked together to develop Pat-INFORMED, a new global platform that could allow government procurement agencies to access information on thousands of individual patents anywhere in the world.
Phlexglobal offers a wide range of trial master file (TMF) related services, supported by a combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise.
Defining Ideal Modular Design for Effective Pharmaceutical Packaging
The essence of modular design is to create an overall architecture where a complex product or system is broken down into discrete component modules or ‘skids’ that perform specific roles and that can be integrated at will into the overall structure.
Will tech giants like Amazon and Google change the pharma sector forever?
The world’s tech giants have recognised vast business opportunities in the healthcare space, and could soon threaten established drug developers and high street pharmacies. What will they have to do to survive?
Cognitive Load and Habit Formation in Pharmaceutical Plants
NSF’s pharma biotech team is committed to developing tailored programmes that make a difference. It teaches fundamental skills/knowledge and links these to leadership objectives such as driving down repeat deviations, simplifying standard operating procedures (SOP) or increasing the knowledge and risk awareness of first line supervisors.
GM babies: He Jiankui and the ethics of gene editing
In late November, Shenzhan’s Southern University of Science and Technology researcher He Jiankui announced on YouTube that his research had resulted in the birth of the first genetically modified children.
‘Nanocarrier’ brings hope for disease-modifying osteoarthritis drugs
Osteoarthritis is a progressive degenerative disease of the joints thought to affect over 30 million adults in the US.
Brexit looms over UK’s attractiveness as a research destination
Stories like the NHS requiring drug makers to stockpile drugs in preparation for a “no-deal” Brexit played a part in negatively affecting industry professionals’ confidence in the UK.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.